BACKGROUND: The metabolic syndrome (MetS) is a risk factor for diabetes, stroke, myocardial infarction, and increased mortality, and has been associated with cognition in some populations. We hypothesized that MetS would be associated with lower Mini-Mental State Examination (MMSE) scores in a multi-ethnic population, and that MetS is a better predictor of cognition than its individual components or diabetes. METHODS: We conducted a cross-sectional analysis among 3,150 stroke-free participants. MetS was defined by the modified National Cholesterol Education Program guidelines-Adult Treatment Panel III (NCEP-ATPIII) criteria. Linear regression and polytomous logistic regression estimated the association between MMSE score and MetS, its individual components, diabetes, and inflammatory biomarkers. RESULTS: MetS was inversely associated with MMSE score (unadjusted β = -0.67; 95% CI -0.92, -0.41). Adjusting for potential confounders, MetS was associated with lower MMSE score (adjusted β = -0.24; 95% CI -0.47, -0.01), but its individual components and diabetes were not. Those with MetS were more likely to have an MMSE score of <18 than a score of ≥ 24 (adjusted OR = 1.94; 95% CI 1.26, 3.01). There was an interaction between MetS and race-ethnicity, such that MetS was associated with lower MMSE score among non-Hispanic whites and Hispanics but not non-Hispanic blacks. CONCLUSIONS: MetS was associated with lower cognition in a multi-ethnic population. Further studies of the effect of MetS on cognition are warranted, and should account for demographic differences.
BACKGROUND: The metabolic syndrome (MetS) is a risk factor for diabetes, stroke, myocardial infarction, and increased mortality, and has been associated with cognition in some populations. We hypothesized that MetS would be associated with lower Mini-Mental State Examination (MMSE) scores in a multi-ethnic population, and that MetS is a better predictor of cognition than its individual components or diabetes. METHODS: We conducted a cross-sectional analysis among 3,150 stroke-free participants. MetS was defined by the modified National Cholesterol Education Program guidelines-Adult Treatment Panel III (NCEP-ATPIII) criteria. Linear regression and polytomous logistic regression estimated the association between MMSE score and MetS, its individual components, diabetes, and inflammatory biomarkers. RESULTS: MetS was inversely associated with MMSE score (unadjusted β = -0.67; 95% CI -0.92, -0.41). Adjusting for potential confounders, MetS was associated with lower MMSE score (adjusted β = -0.24; 95% CI -0.47, -0.01), but its individual components and diabetes were not. Those with MetS were more likely to have an MMSE score of <18 than a score of ≥ 24 (adjusted OR = 1.94; 95% CI 1.26, 3.01). There was an interaction between MetS and race-ethnicity, such that MetS was associated with lower MMSE score among non-Hispanic whites and Hispanics but not non-Hispanic blacks. CONCLUSIONS: MetS was associated with lower cognition in a multi-ethnic population. Further studies of the effect of MetS on cognition are warranted, and should account for demographic differences.
Authors: S A Black; D V Espino; R Mahurin; M J Lichtenstein; H P Hazuda; D Fabrizio; L A Ray; K S Markides Journal: J Clin Epidemiol Date: 1999-11 Impact factor: 6.437
Authors: B J Gurland; D E Wilder; R Lantigua; Y Stern; J Chen; E H Killeffer; R Mayeux Journal: Int J Geriatr Psychiatry Date: 1999-06 Impact factor: 3.485
Authors: Tasnime N Akbaraly; Mika Kivimaki; Martin J Shipley; Adam G Tabak; Markus Jokela; Marianna Virtanen; Michael G Marmot; Jane E Ferrie; Archana Singh-Manoux Journal: Diabetes Care Date: 2009-10-16 Impact factor: 19.112
Authors: Tali Elfassy; Allison E Aiello; Neil Schneiderman; Mary N Haan; Wassim Tarraf; Hector M González; Marc Gellman; Hermes J Florez; Jose A Luchsinger; Clinton B Wright; Ellen Grober; Adina Zeki Al Hazzouri Journal: J Aging Health Date: 2018-03-24
Authors: Bonnie E Levin; Maria M Llabre; Chuanhui Dong; Mitchell S V Elkind; Yaakov Stern; Tatjana Rundek; Ralph L Sacco; Clinton B Wright Journal: J Int Neuropsychol Soc Date: 2014-11-10 Impact factor: 2.892
Authors: Jessica R L Warsch; Tatjana Rundek; Myunghee C Paik; Mitchell S V Elkind; Ralph L Sacco; Clinton B Wright Journal: J Am Geriatr Soc Date: 2013-03-25 Impact factor: 5.562
Authors: Tatjana Rundek; Hannah Gardener; Anita Seixas Dias Saporta; David A Loewenstein; Ranjan Duara; Clinton B Wright; Chuanhui Dong; Bonnie Levin; Mitchell S V Elkind; Ralph L Sacco Journal: J Alzheimers Dis Date: 2020 Impact factor: 4.472